Richards, Merrill & Peterson, Inc. Organon & Co. Transaction History
Richards, Merrill & Peterson, Inc.
- $191 Billion
- Q4 2024
A detailed history of Richards, Merrill & Peterson, Inc. transactions in Organon & Co. stock. As of the latest transaction made, Richards, Merrill & Peterson, Inc. holds 4,500 shares of OGN stock, worth $69,660. This represents 0.04% of its overall portfolio holdings.
Number of Shares
4,500Holding current value
$69,660% of portfolio
0.04%Shares
1 transactions
Others Institutions Holding OGN
# of Institutions
805Shares Held
201MCall Options Held
1.53MPut Options Held
1.07M-
Black Rock Inc. New York, NY32.6MShares$504 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA30.4MShares$471 Million0.01% of portfolio
-
Pacer Advisors, Inc. Malvern, PA11.2MShares$173 Million0.41% of portfolio
-
Massachusetts Financial Services CO Boston, MA9.9MShares$153 Million0.05% of portfolio
-
State Street Corp Boston, MA9.34MShares$145 Million0.01% of portfolio
About Organon & Co.
- Ticker OGN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 254,330,000
- Market Cap $3.94B
- Description
- Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...